Concepedia

Author

Mauricette Brocco

AVL (France)

Also Known As

M BROCCO, M Brocco, M J Brocco, M. BROCCO, M. Brocco, M. J. Brocco, M.J. Brocco, Mauricette Brocco

93

Publications

3.7K

Citations

37

H-Index

57

Concepts

All Affiliations

AVL (France)Servier (France)
MB

About

Mauricette Brocco is an author at AVL (France) specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

27

1.5K

2

Social Sciences

16

18

1.1K

3

Health Sciences

5

5

226

4

Emergency Medicine

1

1

37

5

Exercise Physiology

1

1

37

Mauricette Brocco

×

54

Publications

3.4K

Citations

35

H-Index

YearCitations

(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

Robert D. Schreiber, Mauricette Brocco, Valérie Audinot,

Journal of Pharmacology and Experimental Therapeutics

1995

295

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

Mark J. Millan, Mauricette Brocco, Alain P. Gobert,

Psychopharmacology

2004

244

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5‐HT<sub>2A</sub> sites for PCP‐induced locomotion in the rat

Mark J. Millan, Mauricette Brocco, Alain P. Gobert,

European Journal of Neuroscience

1999

138

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ‘atypical’ antipsychotics, clozapine and risperidone

Rudy Schreiber, Mauricette Brocco, Mark J. Millan

European Journal of Pharmacology

1994

128

A Comparative In Vitro and In Vivo Pharmacological Characterization of the Novel Dopamine D3Receptor Antagonists (+)-S 14297, Nafadotride, GR 103,691 and U 99194

Valérie Audinot, Adrian Newman‐Tancredi, Alain P. Gobert,

Journal of Pharmacology and Experimental Therapeutics

1998

128

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.

M J Millan, J.‐L. PEGLION, Joël Vian,

Journal of Pharmacology and Experimental Therapeutics

1995

126

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

Anne Dekeyne, Clotilde Mannoury la Cour, Alain P. Gobert,

Psychopharmacology

2008

124

S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: II. Functional and Behavioral Profile Compared with GR218,231 and L741,626

Mark J. Millan, Anne Dekeyne, Jean‐Michel Rivet,

Journal of Pharmacology and Experimental Therapeutics

2000

120

S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: II. Behavioral Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine

Mark J. Millan, Anne Dekeyne, Mariusz Papp,

Journal of Pharmacology and Experimental Therapeutics

2001

116

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake

Mauricette Brocco, Anne Dekeyne, Sylvie Veiga,

Pharmacology Biochemistry and Behavior

2002

111

Page 1